CD4 and colitis: Research indicates that using dextran sulfate sodium (DSS) to aggravate colitis in OS mouse models leads to amplified skin inflammation, with a notable increase in circulating CD4+ T cells expressing both skin- and gut-homing receptors (CCR4 and CCR9) [155].